MUMAK: Understand stocks. Recognize innovation. Strategically seize opportunities.

Inside Umbrella

Financial journalism with a track record (via Wikifolio)

Umbrella

Strategy

As of June 26, 2026

Loading chart …

+3.174,0 %

Total performance since Sept. 2012

+28,8 %

Avg. performance per year

+22,9 %

Annual alpha compared to MSCI World

Bayer
Pharmaceuticals, Chemicals & Biotechnology
Germany

Stock: Bayer AG

ISIN: DE000BAY0017

Bayer Logo
Active icon
Continue Umbrella
Revolution Medicines
Healthcare
USA

Stock: Revolution Medicines

ISIN: US76155X1000

Active icon
Continue Umbrella
Johnson & Johnson
Healthcare
USA

Stock: Johnson & Johnson

ISIN: US4781601046

JNJ Logo
Active icon
Continue Umbrella

The Umbrella Strategy briefly explained

“Flexible like an umbrella” describes the core idea behind the UMBRELLA strategy.

The UMBRELLA strategy was developed to assess stocks through various market phases—regardless of whether markets are rising, falling, or moving sideways.

Strategic Allocation

Long-term oriented positioning based on macro trends, industry development, and fundamental data.

Tactical Adjustment

Short-term optimization through ongoing market monitoring, news flow, and technical chart signals.

The goal of the UMBRELLA strategy

Identifying risks and seizing opportunities. The decision-making basis is a continuous process influenced by geopolitical developments, sector analyses, company data, market sentiment, and technical analysis.

A key aspect is continuous adaptation and adjustment

“Change is the only constant”—factors such as political events, sector rotations, company news, market sentiment, and chart patterns are taken into account.

Updates play an important role in this:

They reflect new insights from research and market observation, ensuring that individual decisions can be made based on the most current information. This requires ongoing re-evaluation. The UMBRELLA strategy is an active, learning, and adaptable model for forming one’s own opinion.

Target Audience: Readers interested in capital markets

The content and contextual assessments on MUMAK are therefore primarily aimed at readers interested in capital markets and those with expert knowledge who wish to delve deeper into market mechanisms, investment strategies, and economic correlations.

Latest MUMAK Updates

Ongoing updates on the market, various developments, and the UMBRELLA strategy

Weekly Update

Weekly Market Overview – June 15-21, 2026

The UMBRELLA Strategy is divesting from energy stocks and further expanding its engagement in the healthcare and biotechnology sector.
Next Update
Weekly Update

Weekly Market Overview – June 8-14, 2026

AI and healthcare innovation are shaping the markets. The UMBRELLA Strategy increases its focus on quality companies and reduces cyclical
Next Update
Weekly Update

Weekly Market Overview – June 1-7, 2026

The UMBRELLA strategy has completed its portfolio restructuring, further strengthening its focus on Artificial Intelligence, cloud infrastructure, and data analysis.
Next Update

Research Insights

Detailed classification based on geopolitics, industry, fundamental data, market sentiment, and technical analysis

Bayer AG
Pharmaceuticals, Chemicals & Biotechnology

Valuation Analysis: Bayer AG

ISIN: DE000BAY0017

Bayer AG is in a phase of operational stabilization. While revenue and cash flow remain under pressure, profitability is improving significantly. Management expects further progress in EBITDA by 2026. At the same time, glyphosate litigation, negative free cash flow, and high leverage remain the biggest challenges. Nevertheless, analysts still see attractive upside potential for the stock.
Compass 3 out of 5
Active icon
More research
Revolution Medicines
Healthcare

Valuation Analysis: Revolution Medicines

Active icon
More research
Johnson & Johnson
Healthcare

Valuation Analysis: Johnson & Johnson

Active icon
More research
Eli Lilly and Company
Valuation Analysis

Valuation Analysis: Eli Lilly and Company

Active icon
More research

Valuation Analyses, Industry Analyses, Earnings Analyses, and Company Analyses

All Research Insights

What is MUMAK?

MUMAK stands for “Meine UMbrella AKtien” and is an online financial journal that aims to provide well-founded stock analysis.

The goal is to make the background and methodology of the UMBRELLA Strategy understandable. The content should be explained in a simple, financial journalistic manner, using various approaches, and presented comprehensibly.

MUMAK – financial journalism with a track record.

The UMBRELLA Strategy serves as a systematic approach

  • Consideration of geopolitical developments
  • Classification into industry and macro trends
  • Fundamental Valuation of Companies
  • Market sentiment, news analysis, analyst opinions, and social trader perspectives
  • Discussion of technical analysis

This combination is intended to provide a nuanced view of opportunities and risks within the stock market. This can provide a foundation for your own decision-making processes.

Who is behind MUMAK

MUMAK is being built and constantly further developed by Richard Dobetsberger and Lina Mosentseva.

Richard Dobetsberger

Richard Dobetsberger developed the Umbrella strategy, a structured approach that combines geopolitical developments, fundamental data, market sentiment, and technical analysis. This combination of scientific methodology, geopolitical thinking, and capital market practice forms the foundation.

Lina Mosentseva

Lina Mosentseva has been involved with stock markets, social trading, and financial analysis for over ten years. She combines classical company analysis with modern digital financial communication and ensures that complex market developments are presented in an understandable way.

Together, they combine analytical depth with structured preparation – with the aim of making developments in the stock market comprehensible.

More about MUMAK